These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17016434)

  • 21. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
    Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD
    Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
    Zong WX; Farrell M; Bash J; Gélinas C
    Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S; Gilmore TD
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
    Fan Y; Gélinas C
    Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.
    Hrdlicková R; Nehyba J; Bose HR
    Mol Cell Biol; 2001 Oct; 21(19):6369-86. PubMed ID: 11533227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An NGF-induced Exo70-TC10 complex locally antagonises Cdc42-mediated activation of N-WASP to modulate neurite outgrowth.
    Pommereit D; Wouters FS
    J Cell Sci; 2007 Aug; 120(Pt 15):2694-705. PubMed ID: 17635999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of simulated microgravity on the activation of the small GTPase Rho involved in cytoskeletal formation--molecular cloning and sequencing of bovine leukemia-associated guanine nucleotide exchange factor.
    Higashibata A; Imamizo-Sato M; Seki M; Yamazaki T; Ishioka N
    BMC Biochem; 2006 Jun; 7():19. PubMed ID: 16803636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
    Kralova J; Schatzle JD; Bargmann W; Bose HR
    J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. v-rel and c-rel induce a membrane protein, p75, on avian hematopoietic cells.
    Zhang G; Humphries EH
    Oncogene; 1996 Mar; 12(5):1153-7. PubMed ID: 8649808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
    White DW; Gilmore TD
    Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.
    Kralova J; Liss AS; Bargmann W; Pendleton C; Varadarajan J; Ulug E; Bose HR
    J Virol; 2002 Dec; 76(23):11960-70. PubMed ID: 12414938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the role of v-rel in transcriptional regulation of high mobility group 14.
    Walker AK; Enrietto PJ
    Oncogene; 1996 Jun; 12(12):2515-25. PubMed ID: 8700510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
    Mateos S; Amarir S; Laugier D; Marx M; Calothy G
    Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation.
    Danielsen AJ; Christensen TA; Lovejoy CA; Adelsman MA; Connolly DC; Maihle NJ
    Exp Cell Res; 2004 Jun; 296(2):285-93. PubMed ID: 15149858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AP-1 factors play an important role in transformation induced by the v-rel oncogene.
    Kralova J; Liss AS; Bargmann W; Bose HR
    Mol Cell Biol; 1998 May; 18(5):2997-3009. PubMed ID: 9566919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rho GTPase expression in tumourigenesis: evidence for a significant link.
    Gómez del Pulgar T; Benitah SA; Valerón PF; Espina C; Lacal JC
    Bioessays; 2005 Jun; 27(6):602-13. PubMed ID: 15892119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.
    Liss AS; Bose HR
    J Virol; 2002 May; 76(10):4928-39. PubMed ID: 11967310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of telomerase activation by v-Rel and its contribution to transformation.
    Hrdlicková R; Nehyba J; Liss AS; Bose HR
    J Virol; 2006 Jan; 80(1):281-95. PubMed ID: 16352553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
    Cohen SB; Waha A; Gelman IH; Vogt PK
    Oncogene; 2001 Jan; 20(2):141-6. PubMed ID: 11313943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.